___

• Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295–300. 2- Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607. 3. Erem C, Hacıhasanoglu A, Deger O, Topbaş M, Hosver I, Ersoz HO et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine 2008; 233: 9–20.
• Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992; 8: 67–113.
• Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001; 42: 1007–17.
• Linton KJ, Rosenberg MF, Kerr ID, Higgins CF. Structure of ABC transporters. In: Holland B, Cole SPC, Kuchler K, Higgins CF, editors. ABC proteins from bacteria to man. Amsterdam: Academic Press; 2003. p.65–80.
• Santamarina-Fojo S, Peterson K, Knapper C, Qui Y, Freeman L, Cheng JF et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. PNAS 2000; 97: 7987–92.
• Oram JF. Tangier disease and ABCA1. Biochim Biophys Acta 2000; 1529: 321–30.
• Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000; 2: 399–406.
• Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1- deficient mice. Nat Genet 2000; 24: 192–6.
• Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268: 426–9.
• Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001; 11: 1156–66.
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486–97.
• Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41: 715–22.
• Changren T, Oram JF. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim Biophys Acta 2009; 1791: 563–72.
• Brooks-Wilson A, Marchil M, Clee SM, Zhang L, Roomp K, van Dam M et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22: 336–44.
• Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang L, Yu L et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999; 354: 1341–6.
• Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22: 352–5.
• Iida A, Saito S, Sekine A, Kitamura Y, Kondo K, Mishima C et al. High-density single-nucleotide polymorphism (SNP) map of the 150-kb region corresponding to the human ATP-binding cassette transporter A1 (ABCA1) gene. J Hum Genet 2001; 46: 522–8.
• Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HOF, Roomp K et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103: 1198–205.
• Benton JL, Ding J, Tsai MY, Shea S, Rotter JI, Burke GL et al. Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: multi-ethnic study of atherosclerosis. Atherosclerosis 2007; 193: 352–60.
• Hodoğlugil U, Williamson DW, Huang Y, Mahley RW. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis 2005; 183: 199–212.
• Frikke-Schmidt R, Nordestgaard GB, Jensen GB, Tybjaerg- Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004; 114: 1343–53.
• Li J, Wang L, Li Z, Pan W. Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol 2009; 36: 567–70.
• Singaraja RR, Brunham LR, Visscher H, Kastelein JJP, Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003; 23: 1322–32.
• Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005; 115: 2047–58.
• Inoue H, Ferrer J, Wellin CM, Elbein SC, Hoffman M, Mayorga R et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996; 45: 825–31.
• Hansen T, Echwald SM, Hansen L, Moller AM, Almind K, Clausen JO et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 1998; 47: 598–605.
• ‘t Hart LM, de Knijff P, Dekker JM, Stolk RP, Nijpels G, van der Does FEE et al. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with type II diabetes mellitus in Dutch Caucasians. Diabetologia 1999; 42: 617–20.
• ‘t Hart LM, Dekker JM, van Haeften TW, Ruige JB, Stehouwer CDA, Erkelens DW et al. Reduced second phase insulin secretion in carriers of sulphonylurea receptor gene variant associating with type II diabetes mellitus. Diabetologia 2000; 43: 515–9.
• Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Kekalainen P, Mykkanen L et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 2000; 23: 70–3.
• Reis AF, Ye W, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 2000; 107: 138–44.
• Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G et al. Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003; 52: 568–72.
• van Dam RM, Hoebee B, Seidell JC, Schaap MM, deBruin TWA, Feskens EJM. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabetic Med 2005; 22: 590–8.
• Yokoi N, Kanamori M, Horikawa Y, Takeda J, Sanke T, Furuta H et al. Association studies of variants in the genes involved in pancreatic β-cell function in type 2 diabetes in Japanese subjects. Diabetes 2006; 55: 2379–86.
• Altshuler D, Hirschorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76–80.
• Weisnagel SJ, Rankinen T, Nadeu A, Rao DC, Chagnon YC, Perusse L et al. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene. Diabetes 2001; 50: 697–702.
• Reis AF, Hani EH, Beressi N, Robert JJ, Bresson JL, Froguel P et al. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects. Diabetes Metab 2002; 28: 209–15.
• Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ. Role of common sequence variants in insulin secretion in familial type 1 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1 alpha genes. Diabetes Care 2001; 24: 472–8.
• Zychma MJ, Gumprecht J, Strojek K, Grzeszczak W, Moczulski D, Trautsolt W et al. Sulfonylurea receptor gene 16-3 polymorphism-association with sulfonylurea or insulin treatment in type 2 diabetic subjects. Med Sci Monit 2002; 8: CR512–5.
• Robitaille J, Despres JP, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from Quebec Family Study. Clin Genet 2003; 63: 109–16.
• Akkiprik M, Sertoğlu FÖ, Çağlayan S, Aral C, Özışık G, Atabey Z et al. Association of ACP1 genotypes and clinical parameters in patients with metabolic syndrome. Turk J Med Sci 2011; 41: 533–41.
• Gemalmaz M, Aydın S, Başak O, Dişcigil G, Karul A. Prevalence of the metabolic syndrome in a rural Turkish population: comparison and concordance of two diagnostic criteria. Turk J Med Sci 2008; 38: 159–65.